{"id":"W2022184484","doi":"10.2174/1381612053382205","title":"Development of Molecular Targeted Anticancer Agents: Successes, Failures and Future Directions","year":2005,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Imatinib; Medicine; Trastuzumab; Myeloid leukemia; Targeted therapy; Bevacizumab; Chronic myelogenous leukemia; Clinical trial; Cancer; Bioinformatics; Breast cancer; Cancer research; Leukemia; Immunology; Biology; Internal medicine; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006581978,0.0005769865,0.001698607,0.0003949966,0.0001167208,0.00004497826,0.0003052266,0.0003080406,0.001293265],"category_scores_gemma":[0.0001376624,0.0004575854,0.0003025207,0.0008204764,0.0002744349,0.00007369498,0.0001763246,0.001285992,0.0000723091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004511687,"about_ca_system_score_gemma":0.002015292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003721913,"about_ca_topic_score_gemma":0.000001182663,"domain_scores_codex":[0.9962553,0.0004241136,0.001008933,0.0007312395,0.0009213295,0.0006590405],"domain_scores_gemma":[0.998255,0.0002215178,0.0002116487,0.0004131189,0.0002363196,0.0006623644],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000409876,0.0003279047,0.000003285577,0.02537801,0.0004209768,0.00003539752,0.00007344623,2.954664e-7,0.00004906277,0.0001890018,0.002157825,0.9713238],"study_design_scores_gemma":[0.0006209911,0.00005848594,0.000008945213,0.008382226,0.001448487,0.00004938095,0.000009847943,0.00005785259,0.0005643296,0.000005202066,0.9884052,0.0003891091],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004484183,0.9940104,0.002122552,0.0005071901,0.0007532953,0.002234122,0.00005529882,0.00008028104,0.0002323938],"genre_scores_gemma":[0.0000328077,0.9900207,0.008338286,0.00005553519,0.0008533375,0.0004200641,0.0001221435,0.00009705437,0.00006005968],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9862473,"threshold_uncertainty_score":0.9997876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2605662726175213,"score_gpt":0.5193172596919667,"score_spread":0.2587509870744454,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}